CRP and metabolic syndrome: On the other hand, subjects who exhibited MetS but had low CRP levels (MetS+CRPlow, Figure 6C) showed a slight strengthening of the association between dihydroceramides and ceramides, without other differences, when compared with MetS−CRPlow subjects (Figure 6A).